Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Orbit (Amsterdam, Netherlands)|November 26, 2009
Utility values in patients with acquired anophthalmusChristoph Hirneiss, Aljoscha S Neubauer, Tina R Herold, et al.
Retina (Philadelphia, Pa.)|March 24, 2022
LONG-TERM EFFICACY OF FLUOCINOLONE IN EYES WITH IRIS-LENS DIAPHRAGM DISRUPTION AND PCME WITH MEDICATION FIXED IN THE SCLERA (MEFISTO)Tina R Herold, Efstathios Vounotrypidis, Raffael Liegl, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 10, 2021
Subthreshold laser therapy with a standardized macular treatment pattern in chronic central serous chorioretinopathyBenedikt Schworm, Jakob Siedlecki, Leonie F Keidel, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 20, 2021
[Retinal imaging of vitreomacular traction diseases]Ricarda G Schumann, Tina R Herold, Christos Haritoglou, et al.
Ophthalmology and Therapy|May 12, 2025
Real-World Data on Morphological and Functional Responses After Switching to Faricimab in Recalcitrant, Chronic Diabetic Macular EdemaViktoria Deiters, Anna Lorger, Franziska Eckardt, et al.
Journal of Clinical Medicine|October 29, 2025
Extended Real-World Efficacy of Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: 9-Month Follow-Up ResultsMichael Hafner, Tina R Herold, Alexander Kufner, et al.
Scientific Reports|May 23, 2020
Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to afliberceptBenedikt Schworm, Nikolaus Luft, Leonie F Keidel, et al.
Journal of Clinical Medicine|April 12, 2025
Switching to Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: Initial Real-World Efficacy OutcomesMichael Hafner, Tina R Herold, Alexander Kufner, et al.
Pageof 2